According to filings with the U.S. Securities and Exchange Commission, Zimmer Biomet is raising $216,086,331.00 in new funding. Sources indicate as part of senior management Director, Christopher Begley played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world.

To learn more about Zimmer Biomet, visit http://www.zimmerbiomet.com/

Contact:
Christopher Begley, Director
574-373-3121

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.